Treatment of Episcleritis Secondary to Rheumatoid Arthritis

Initial Management Approach

• The American College of Rheumatology recommends treating episcleritis in rheumatoid arthritis with topical corticosteroids or NSAIDs alongside optimization of the underlying RA disease control, as it typically parallels disease activity and responds well to local therapy without requiring systemic immunosuppression 1, 2
• Topical corticosteroids or topical NSAIDs are the mainstay of treatment for RA-associated episcleritis, according to the European League Against Rheumatism 1, 3, 4

Disease Activity Correlation

• Episcleritis in RA generally parallels underlying disease activity, so optimizing RA treatment is essential, as stated by the American College of Rheumatology 2, 4
• The condition often improves when systemic RA inflammation is controlled, according to the European League Against Rheumatism 1, 3

When to Escalate Treatment

• Oral NSAIDs should be considered for persistent or recurrent symptoms that don't respond to topical therapy, at the minimum effective dose for the shortest duration, due to cardiovascular and gastrointestinal risks, as recommended by the American Heart Association 1, 3, 6
• For patients ≥75 years, topical NSAIDs are strongly preferred over oral formulations, according to the American Geriatrics Society 6

Ophthalmology Referral Guidelines

• Simple episcleritis does not require ophthalmology referral if diagnosis is clear and symptoms are mild, according to the American Academy of Ophthalmology 2, 4
• Any suspicion of scleritis (severe pain, deep injection, vision changes) requires urgent ophthalmology referral, as stated by the American College of Rheumatology 1, 3

Monitoring and Follow-Up

• If no improvement after 2-4 weeks of topical therapy, reassess diagnosis and consider ophthalmology referral, as recommended by the European League Against Rheumatism 6
• Monitor for recurrence, as nodular forms are more likely to recur, according to the American Academy of Ophthalmology 6

Common Pitfalls to Avoid

• Do not mistake scleritis for episcleritis - the presence of severe pain should immediately raise concern for scleritis, as stated by the American College of Rheumatology 1, 3
• Do not use systemic immunosuppression for simple episcleritis - topical therapy is sufficient in most cases, according to the European League Against Rheumatism 1, 3
• Do not ignore the underlying RA disease activity - episcleritis often reflects inadequate systemic control, as recommended by the American College of Rheumatology 2, 4